Deferred Tax Assets, Valuation Allowance of Bionano Genomics, Inc. from 31 Dec 2017 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Bionano Genomics, Inc. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2017 to 31 Dec 2024.
  • Bionano Genomics, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2024 was $140,472,000, a 27% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

Bionano Genomics, Inc. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $140,472,000 +$29,759,000 +27% 31 Dec 2024 10-K 31 Mar 2025 2024 FY
Q4 2023 $110,713,000 -$11,303,000 -9.3% 31 Dec 2023 10-K 31 Mar 2025 2024 FY
Q4 2022 $122,016,000 +$38,865,000 +47% 31 Dec 2022 10-K 05 Mar 2024 2023 FY
Q4 2021 $83,151,000 +$12,878,000 +18% 31 Dec 2021 10-K 09 Mar 2023 2022 FY
Q4 2020 $70,273,000 +$22,078,123 +46% 31 Dec 2020 10-K 01 Mar 2022 2021 FY
Q4 2019 $48,194,877 +$6,786,990 +16% 31 Dec 2019 10-K 23 Mar 2021 2020 FY
Q4 2018 $41,407,887 +$5,637,286 +16% 31 Dec 2018 10-K 10 Mar 2020 2019 FY
Q4 2017 $35,770,601 31 Dec 2017 10-K 14 Mar 2019 2018 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.